Augur Signals: News Feed

In a notable move, Williams Gregg, a major insider at Vivani Medical, Inc. (VANI), has bolstered their holdings with a new acquisition of 7,620 shares at $1.01 each, totaling $7,696.20. This purchase increases Gregg's total ownership to 721,411 shares, showcasing a robust belief in the firm's future. Over the past year, Gregg has consistently invested in VANI, with share prices ranging from $0.86 to $1.08. Amidst the biotech sector's volatility, VANI maintains a steady share price with a market cap of USD 50,818,800, cash reserves of USD 32,486,000, and debt of USD 20,988,000 …

Retractable Technologies, Inc. saw a significant insider transaction when Shaw Thomas J, the PRESIDENT AND CEO, bought 3,222 shares at $1.22 each, increasing his direct ownership to 14,176,292 shares. With a history of 42 non-derivative transactions, Shaw's consistent investment behavior aligns with the company's recent short-term stock uptick, despite a negative profit margin. The company holds more cash than debt, with a market capitalization of USD 35,625,268, indicating a potentially bullish outlook from insiders.

McWherter Charles, President of R&D at CymaBay Therapeutics, Inc. (CBAY), sold 2,250 shares at $23.67 each, totaling $55,125. Remaining with 15,000 shares, McWherter's transaction coincides with CymaBay's stock volatility and growth. With 192 insider transactions over the past year, McWherter's activity reflects a pattern of option exercises and sales. Despite operating at a loss, CymaBay's cash reserves of USD 213,844,000 bolster its clinical research endeavors. The sale may indicate personal financial planning rather than a judgment on CymaBay's future.

OPKO Health, Inc., a significant entity in the Diagnostics & Research industry, has seen Dr. Jane Hsiao, Vice Chairman & CTO, purchase 150,000 shares at $0.95 each, totaling $142,500. This insider move increases Dr. Hsiao's ownership to 27,999,880 shares and may signal confidence in the company's future despite recent stock volatility, with a ten-day price change of -37.21% and a fifty-two-week price change of -58.93%. The company's market capitalization stands at USD 997,243,520, with a challenging financial outlook showing negative cash flow and profit margins. This insider activity, against the backdrop of the company's financial …